Company Active PRIVATE-LIMITED-GUARANT-NSC

Company profile

Genome Research Limited

UK company 02742969, incorporated on 20 August 1992.

Wellcome Sanger Institute

We are a world-leading genomics research institute. Our work helps improve human health and understand life on Earth

Company number
02742969
Incorporated
20 Aug 1992
Companies House status
Active

Company identity

Founded / incorporated
20 August 1992

Company number 02742969

Verify at Companies House
Legal name
GENOME RESEARCH LIMITED
Company type
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Region
East of England
Registered address
WELLCOME SANGER INSTITUTE WELLCOME GENOME CAMPUS
HINXTON
SAFFRON WALDEN
ENGLAND
CB10 1SA
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller Controls 4
1
Company Active PRIVATE-LIMITED-GUARANT-NSC
Genome Research Limited
CRN 02742969
2
Direct and ultimate controller Active PRIVATE-LIMITED-GUARANT-NSC

Company events

Reference milestones and recent Companies House filing stream events.

5 events
30 Jun
2027

Accounts due

Accounts Due

Next accounts due date

12 Jun
2027

Confirmation statement due

Confirmation Due

Next confirmation statement due date

29 May
2026

Confirmation statement filed

Confirmation

Last confirmation statement made up date

30 Sep
2025

Accounts filed

Accounts

Last accounts made up date

20 Aug
1992

Incorporated

Inception

Company registered at Companies House

Public funding

3 awards
First funded
2011
Funded years
2011, 2013, 2017
Age at first award
18 years

Projects

2017 Feasibility Studies

Cambridge Autonomous Bus System Feasibility Study

1 Jul 2017 to 30 Jun 2018

Awarded
£30,000
Total cost £30,000

The Cambridge Autonomous Bus System Feasibility Study will examine the opportunity to use new, electric, autonomous mini-buses to provide much needed transport links between Cambridge's science campuses, park & ride locations and rail stations. These vehicles and special paths could provide a significant improvement in traffic congestion, improve air qual...

2013 Collaborative R&D

Personalised iPS Cell Culture System

1 Nov 2013 to 31 Oct 2015

Awarded
£64,559
Total cost £64,559

We plan to develop a novel, automated cell culture system specifically designed for iPSC and autologous cell culture. Early stage iPS cell culture is very labour intensive since cells must be monitored and fed daily for many weeks. For clinical applications cells must be cultured in a GMP clean room environment, with high staff and infrastructure costs. O...

2011 Collaborative R&D

High-speed single molecule detection combining short DNA probes and barcoding bioinformatics for use as a new broad spectrum point-of-care diagnostic

1 Jan 2011 to 31 Dec 2013

Awarded
£227,708
Total cost £227,708

Based in Cambridge, Base4 is developing a single-molecule detector with the capacity for detection of up to 1 billion single molecules per second, thousands of times faster than is otherwise possible. Entirely solid-state, there is a well-worn path towards large scale production and the cost of consumables will be very low. Not reliant on enzymes or patho...

Product types

Collaborative R&D Feasibility Studies